Our Global Presence
Sentiss operates on geography specific strategies which include sales and marketing, distribution and licensing arrangements. The subsidiary in Switzerland, Sentiss AG, serves as the hub for Sentiss’ commercial operations globally. The sales, marketing and distribution operations are managed through Sentiss subsidiaries in Russia and USA. For all enquiries please contact us
Others Market
Sentiss has developed a number of CTD dossiers to offer licensing, distribution and supply for other markets. We are seeking potential partners who are keen to collaborate with us for their respective markets.
Partnering Philosophy
Sentiss’ business development strategy includes:
- Product development and supply
- Marketing and distribution through strategic partners
- Strategic partnership and Mergers & Acquistions
- In-licensing of products
- Out-licensing of product dossiers
- Contract manufacturing and technology transfer
Contract Manufacturing and Technology Transfer
Our Contract manufacturing services are effectively managed through a dedicated team of Program Managers who service each customer contract with utmost confidentiality and focus on On-time and In-full servicing of customer orders.
We have successfully managed technology development and transfer projects in collaboration with large customers and are strongly positioned to render these services for other global companies.
In-Licensing
Sentiss views partnering and collaborating as an important strategic approach that will complement its growth in the existing markets of Russia, CIS, and India, as well as other international markets.
Its partnering approach is to build mutually rewarding long-term business relationships based on an exclusive marketing business model for the targeted geographies, as well as co-marketing or co-development models, including clinical trials of products that are a prerequisite for regulatory approvals.
Out-Licensing
Sentiss’ formulation development expertise enables the development of high quality generic products in Sterile Blow-Fill-Seal vials and conventional 3-piece bottles. Its robust R&D pipeline of drugs is focused on:
- Generic Products
- CE Mark Products
- OTC Products
- 505(b)(2) and Para IV Products
Russia & CIS
Provis